The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase ib trial to evaluate the safety and efficacy of quinacrine plus capecitabine in patients with refractory metastatic colorectal cancer.
 
Arthur Winer
No Relationships to Disclose
 
Namrata Vijayvergia
Consulting or Advisory Role - Novartis
Research Funding - Merck (Inst)
 
Steven J. Cohen
Consulting or Advisory Role - Bayer; Exelixis
 
Crystal S. Denlinger
Honoraria - Dava Oncology
Consulting or Advisory Role - Bayer; BeiGene; Bristol-Myers Squibb; Lilly; Merck
Research Funding - Advaxis (Inst); Agios (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Merrimack (Inst); OncoMed (Inst)
 
Igor A. Astsaturov
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Caris Life Sciences; Guardant Health
Speakers' Bureau - Caris Life Sciences
 
Efrat Dotan
Consulting or Advisory Role - ARMO BioSciences; Boston Biomedical
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); OncoMed (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jean-Nicolas Gallant
No Relationships to Disclose
 
Edward W Wang
No Relationships to Disclose
 
Miriam Kunkel
No Relationships to Disclose
 
Bora Lim
Consulting or Advisory Role - AstraZeneca; Novartis
Research Funding - Calithera Biosciences; Genentech; Merck; Puma Biotechnology; Takeda
 
Harold A. Harvey
Consulting or Advisory Role - Genentech
Research Funding - Genentech (Inst); Janssen (Inst); Tercica (Inst)
 
Jeffrey Michael Sivik
No Relationships to Disclose
 
Lanlan Zhou
No Relationships to Disclose
 
Kenneth Korzekwa
No Relationships to Disclose
 
Karen Ruth
No Relationships to Disclose
 
Eric A. Ross
Patents, Royalties, Other Intellectual Property - Method for Screening Muscle Invasive Bladder Cancer Patients for Neoadjuvant Chemotherapy Responsiveness (Inst)
 
Wafik S. El-Deiry
Stock and Other Ownership Interests - Oncoceutics; p53-Therapeutics
Research Funding - Bayer; Loxo; Morphotek; Tarmeta Biosciences
Patents, Royalties, Other Intellectual Property - Patent on TIC10 (ONC201); Patents pending on the use of small molecules to target mutant p53
Other Relationship - Caris Life Sciences